Clinical and Experimental Hepatology is a pivotal journal dedicated to advancing the field of hepatology, providing a platform for researchers, clinicians, and students to disseminate and explore groundbreaking findings. Published by TERMEDIA PUBLISHING HOUSE LTD in Poland, this journal serves as a vital resource for professionals seeking to enhance their knowledge and contributions in the realm of liver diseases and their management. With an impact factor reflective of its growing influence—ranking Q3 in Hepatology for the year 2023 and holding the 49th position out of 82 in Scopus Medicine Hepatology ranks—this publication underscores the significance of innovative research in this specialized domain. While it currently operates through a subscription model rather than open access, it bridges the gap in hepatological literature by featuring a diverse array of scholarly articles, case reports, and reviews from 2015 to 2024. Researchers and health professionals alike will find valuable insights that can enhance clinical practice and inform future studies, solidifying its importance in the hepatology community.

HPB is a premier journal dedicated to advancing the fields of Gastroenterology and Hepatology, published by Elsevier Science Ltd. With an impressive impact factor reflective of its high-quality research output, HPB has earned its place as a Q1 journal in Gastroenterology and Q2 in Hepatology as of 2023. The journal, available in both print and electronic formats (ISSN: 1365-182X; E-ISSN: 1477-2574), serves as a vital platform for multidisciplinary research, encompassing clinical and experimental studies, aimed at improving patient care and outcomes related to liver and biliary diseases. Since its inception in 2000, HPB has published influential articles that have shaped practice and policy in the field. Located in the United Kingdom, at 125 London Wall, London EC2Y 5AS, the journal is poised to continue its mission of fostering innovation and collaboration among researchers, healthcare professionals, and academicians worldwide.

Clinical and Experimental Gastroenterology is a prestigious Open Access journal published by DOVE MEDICAL PRESS LTD, dedicated to advancing the field of gastroenterology through rigorous research and innovative insights. With its ISSN 1178-7023, the journal has established a significant presence since its inception in 2008 and has been actively contributing to the academic landscape from New Zealand. The journal has attained a commendable Q2 rank in the Gastroenterology category as of 2023, placing it in the upper-tier percentile of similar journals. It currently ranks #57 out of 167 in the Scopus database, highlighting its relevance and impact in the field at the 66th percentile. Encompassing a wide range of topics within gastroenterology, the journal aims to foster discussion and disseminate findings that enhance clinical practices and patient care. Researchers, healthcare professionals, and students alike will find this journal an invaluable resource for cutting-edge research and developments in gastrointestinal health.

Gastrointestinal Disorders is a prominent open-access journal published by MDPI, based in Switzerland, that focuses on the latest research and innovations in the fields of gastroenterology, hepatology, and immunology. Since its inception in 2019, the journal has provided a vital platform for researchers and professionals to disseminate their findings, engaging with a global audience keen on advancing knowledge in gastrointestinal health. With a dedicated commitment to high-quality, peer-reviewed articles, Gastrointestinal Disorders has gained recognition in 2023, achieving Q3 status in gastroenterology and notable rankings in several other categories, including a respectable position in the quartiles for hepatology, immunology, and oncology. Despite its recent establishment, the journal has quickly become a valuable resource, facilitating open access to critical insights in the study of gastrointestinal diseases and their management, ensuring that emerging research is readily available to inform clinical practice and educate future professionals.

Journal of Pancreatology, published by Lippincott Williams & Wilkins, serves as a vital resource in the fields of Endocrinology, Diabetes and Metabolism, and Hepatology. This Open Access journal, established to disseminate cutting-edge research and advancements in pancreatic health, has witnessed a substantial rise since its inception in 2018, with converged publications spanning through 2024. Although currently ranked in the Q3 category across multiple disciplines, the journal continually seeks to elevate the discourse around pancreatic diseases and endocrine functions through high-quality articles and comprehensive studies. Researchers, professionals, and students alike will find valuable insights that can drive future investigations and clinical applications. The journal is accessible from anywhere in the world, ensuring that critical knowledge in this important field reaches a wide audience without barriers. Explore the Journal of Pancreatology to stay at the forefront of pancreatic research and contribute to meaningful developments in medical science.

Cancer Research and Treatment is a premier academic journal published by the Korean Cancer Association that focuses on advancing scientific knowledge and clinical practices in the fields of cancer research and oncology. With an ISSN of 1598-2998 and an E-ISSN of 2005-9256, the journal showcases cutting-edge research articles, clinical trials, and comprehensive reviews that address the multifaceted challenges in cancer treatment and management. Published in South Korea, this journal has established itself as a critical resource, evidenced by its Q1 rank in Oncology and Q2 rank in Cancer Research, reflecting its influence and stature within the academic community. The impact of research disseminated through Cancer Research and Treatment is underscored by its significant percentile rankings in Scopus, with notable positions in both the pharmaceutical and biological sectors. This journal aims to bridge the gap between laboratory research and clinical application, providing a platform for researchers, healthcare professionals, and students to enhance their understanding of cancer-related innovations and therapeutic strategies. Readers will benefit from rich content that not only discusses the latest advancements but also engages with pressing global health issues related to cancer.

Zentralblatt für Chirurgie is a pivotal journal in the realm of surgical medicine, serving as an essential resource for researchers, professionals, and students in the field. Published by Georg Thieme Verlag KG, this journal has been disseminating vital surgical research since its inception in 1947, fostering a robust dialogue among healthcare practitioners worldwide. While currently positioned in the Q4 quartile for both Medicine and Surgery in 2023, Zentralblatt für Chirurgie remains a valuable platform for disseminating innovative findings, case studies, and critical reviews that shape contemporary surgical practices. With a rich archive and a commitment to enhancing surgical knowledge, this journal is ideally suited for those seeking to stay abreast of current trends and developments within the medical landscape. Although it does not provide open access, its contents continue to be a crucial asset for institutions and professionals dedicated to surgical excellence.

World Journal of Gastrointestinal Oncology, published by BAISHIDENG PUBLISHING GROUP INC, stands as a pivotal resource in the evolving fields of gastroenterology and oncology, particularly focused on the intricate relationship between gastrointestinal disorders and cancer. Established in 2014, the journal continues to publish influential research, boasting a commendable Q2 ranking in both the gastroenterology and oncology categories for 2023, which underscores its importance in these critical medical domains. With a diverse range of topics and studies, it serves as an essential platform for researchers, healthcare professionals, and students aiming to stay informed about the latest advancements and innovations in gastrointestinal oncology. Though currently not classified as open access, the journal's rigorous peer-review process ensures the dissemination of high-quality research that significantly contributes to clinical practice and patient care. Its positioning in the Scopus rankings also highlights its competitive standing within the scientific community, fostering discussions that are crucial for advancing both fields. Explore the latest insights and findings to enhance your understanding and contribute to the ongoing dialogue in gastrointestinal health and oncology.

Clinical and Experimental Otorhinolaryngology is a leading open-access journal published by the Korean Society of Otorhinolaryngology, dedicated to advancing knowledge in the fields of otorhinolaryngology and surgery. With its strong commitment to disseminating cutting-edge research since its inception in 2008, the journal is indexed by Scopus, holding impressive ranks of #90 out of 551 in Surgery and #22 out of 123 in Otorhinolaryngology, placing it in the top quartile (Q1) of both categories as of 2023. Clinical and Experimental Otorhinolaryngology not only provides a platform for researchers and professionals to share their findings but also fosters collaboration and innovation in this ever-evolving field. This journal serves as an essential resource for scholars and practitioners alike, addressing contemporary issues and emerging techniques relevant to clinical practice and experimental research in otorhinolaryngology. With its wide reach and authoritative content, the journal is instrumental in shaping the future of patient care and surgical practices worldwide.

International Journal of Hepatobiliary and Pancreatic Diseases (ISSN: 2230-9012) is a pivotal publication dedicated to advancing knowledge in the fields of hepatology, biliary tract, and pancreatic diseases. Published by EDORIUM JOURNALS, this esteemed journal aims to provide a platform for cutting-edge research, critical reviews, and clinical studies that address complex issues affecting the liver, biliary system, and pancreas. With a strong commitment to open access, the journal facilitates the dissemination of vital findings to researchers, clinicians, and healthcare professionals worldwide. Recognizing the importance of these disciplines in combating global health challenges, the International Journal of Hepatobiliary and Pancreatic Diseases welcomes submissions that contribute to the understanding of pathophysiology, treatment advancements, and innovative surgical techniques. For researchers eager to impact patient care and medical knowledge, this journal serves as an essential resource in the ongoing dialogue on liver and pancreatic health.